Literature DB >> 1407658

A lipoxygenase pathway of arachidonic acid metabolism mediates FMRFamide activation of a potassium current in an identified neuron of Helisoma.

F H Bahls1, J E Richmond, W L Smith, P G Haydon.   

Abstract

The neuropeptide FMRFamide causes a presynaptic inhibition of neurotransmitter release from neuron B5 of Helisoma. In this study we demonstrate that one of FMRFamide's actions is to activate an outwardly rectifying potassium current. Arachidonic acid also activates an outward current in B5. The phospholipase A2 inhibitor, 4-bromophenacylbromide (BPB), and nordihydroguaiaretic acid (NDGA), an inhibitor of arachidonic acid metabolism, but not indomethacin, block FMRFamide's activation of the potassium current. Taken together these data demonstrate that one of FMRFamide's presynaptic actions is to activate a potassium current through a lipoxygenase pathway of arachidonic acid metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407658     DOI: 10.1016/0304-3940(92)90497-u

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Roles of G-protein beta gamma, arachidonic acid, and phosphorylation inconvergent activation of an S-like potassium conductance by dopamine, Ala-Pro-Gly-Trp-NH2, and Phe-Met-Arg-Phe-NH2.

Authors:  H van Tol-Steye; J C Lodder; H D Mansvelder; R J Planta; H van Heerikhuizen; K S Kits
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

2.  Phe-Met-Arg-Phe-amide activates a novel voltage-dependent K+ current through a lipoxygenase pathway in molluscan neurones.

Authors:  K S Kits; J C Lodder; M J Veerman
Journal:  J Gen Physiol       Date:  1997-11       Impact factor: 4.086

3.  Oxidative-stress induced increase in circulating fatty acids does not contribute to phospholipase A2-dependent appetitive long-term memory failure in the pond snail Lymnaea stagnalis.

Authors:  Emily Beaulieu; Julie Ioffe; Shawn N Watson; Petra M Hermann; Willem C Wildering
Journal:  BMC Neurosci       Date:  2014-05-01       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.